Loading clinical trials...
Loading clinical trials...
Only about 15% of the potential candidates for lung donation are considered suitable for transplantation. A new method for ex vivo lung perfusion (EVLP) has been developed and can be used for evaluati...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
InCor Heart Institute
Collaborators
NCT07552779 · Coronavirus Disease 2019, Coronavirus Disease 2019 (COVID-19), and more
NCT06691971 · Subject Presenting Wheeze, Asthma, and more
NCT04263038 · Pulmonary Embolism, Embolism, and more
NCT05907564 · Pulmonary Embolism, Embolism, and more
NCT04657120 · Pulmonary Embolism, Embolism, and more
INCOR - Heart Institute
São Paulo, São Paulo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions